Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:GTH

Genetron (GTH) Stock Price, News & Analysis

Genetron logo

About Genetron Stock (NASDAQ:GTH)

Key Stats

Today's Range
$4.02
$4.05
50-Day Range
$3.85
$4.03
52-Week Range
$2.08
$4.05
Volume
412,600 shs
Average Volume
51,662 shs
Market Capitalization
$127.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.

Receive GTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter.

GTH Stock News Headlines

Why buying gold might be a mistake
Something strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level.
Genetron (NASDAQ: GTH)
Genetron Holdings Ltd. ADR
See More Headlines

GTH Stock Analysis - Frequently Asked Questions

Genetron Holdings Limited (NASDAQ:GTH) issued its earnings results on Sunday, May, 23rd. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.30. The firm earned $14.05 million during the quarter.
Read the conference call transcript
.

Shares of Genetron reverse split before market open on Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

Genetron (GTH) raised $162 million in an initial public offering on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genetron investors own include NVIDIA (NVDA), ServiceNow (NOW), Broadcom (AVGO), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META) and Arista Networks (ANET).

Company Calendar

Last Earnings
5/23/2021
Today
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:GTH
Fax
N/A
Employees
993
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$94.34 million
Book Value
$2.63 per share

Miscellaneous

Free Float
N/A
Market Cap
$127.43 million
Optionable
Not Optionable
Beta
0.51
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:GTH) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners